Today: 9 June 2026
Joby Aviation stock: the $1.2 billion deal behind JOBY’s sharp slide
30 January 2026
1 min read

Joby Aviation stock: the $1.2 billion deal behind JOBY’s sharp slide

New York, Jan 30, 2026, 09:12 EST — Premarket

Shares of Joby Aviation Inc (JOBY.N) were steady near $11.14 premarket on Friday, following a steep nearly 17% slide a day earlier. The electric air-taxi maker is raising new capital, which weighed on investor sentiment.

This move is significant since Joby is raising funds at a discount. The deal includes new shares and hedging activity linked to convertible bonds — a combination that can pressure the stock despite the added cash boosting the company’s runway.

The eVTOL (electric vertical take-off and landing) race continues to draw public market funding, even as certification and manufacturing costs burn through cash long before passenger fares start flowing in.

Joby priced an upsized financing package totaling more than $1 billion, consisting of $600 million in 0.75% convertible senior notes due 2032 and 52,863,437 common shares at $11.35 each. The deal surpassed the initial target the company had set. Settlement is planned for Feb. 2. Underwriters hold 30-day options to purchase an extra $90 million in notes and 7,929,515 shares, Joby said.

Convertible notes are bonds that can later turn into shares if specific conditions are met. A “capped call” is an options trade the issuer purchases to cap the dilution existing shareholders experience when those bonds convert, though it doesn’t eliminate dilution altogether.

The notes prospectus details a separate “delta offering” linked to the hedge trade: Morgan Stanley is offloading 5,286,343 borrowed shares to help certain note buyers manage risk. Joby won’t see any proceeds from these borrowed shares. The filing lists Joby’s last reported sale price at $13.37 on Jan. 28, which means the $11.35 equity price is roughly a 15% discount to that figure. SEC

Joby announced earlier this week that it intends to use the proceeds, combined with existing cash reserves, to advance certification and manufacturing efforts and gear up for commercial operations. The firm is working on an all-electric vertical take-off and landing aircraft designed for air-taxi services.

Traders are fixated on the dilution math, not the coupon. Joby plans to issue tens of millions of shares, and convertible-arbitrage hedging could trigger selling at inconvenient moments.

The risk goes both ways. If certification or production delays occur, or capital markets tighten once more, the company might have to raise funds again — and each round tends to weigh heavier on the stock than the previous one.

The next key date is the Feb. 2 settlement for the offerings. What happens in the weeks after, with any exercise of the underwriters’ overallotment options, will decide the total new supply hitting the market.

Stock Market Today

  • Semiconductor Stock Poised to Surpass Micron Technology by 2028
    June 9, 2026, 10:18 AM EDT. Micron Technology has surged nearly 800% recently, driven by high demand and pricing power in memory chips, pushing its market cap past $1 trillion. However, analysts predict supply constraints easing by 2028 could cause earnings to peak and decline, potentially halving share value to around $517.50. Meanwhile, a major semiconductor competitor valued around $650 billion is expanding production, potentially surpassing Micron's value by 2028. The industry faces cyclical dynamics as new manufacturing capacity comes online globally, impacting pricing and earnings. Investors are watching these shifts closely for long-term positioning amid evolving chip supply and demand.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
NIO stock climbs before the bell on “World Model” software push — deliveries next test
Previous Story

NIO stock climbs before the bell on “World Model” software push — deliveries next test

Silver price today: XAG/USD tumbles near $100 as Warsh Fed pick jolts metals
Next Story

Silver price today: XAG/USD tumbles near $100 as Warsh Fed pick jolts metals

Go toTop